The global esoteric testing market size reached USD 20.85 Billion in 2021 and is expected to register a revenue CAGR of 11.7% during the forecast period, according to latest analysis by Emergen Research. One of the main factors driving revenue growth of the market is rising prevalence of infectious and chronic diseases. Rising prevalence of chronic disorders presents a significant opportunity for innovative research into unique molecules that can be altered to create brand-new medications. One of the major factors driving revenue growth of the market is rising number of successful research and development outcomes in the area of cellular immunology that are used to treat conditions such as cardiovascular disease, adenocarcinomas, neurological illnesses, and others.
The report also offers estimations and predictions about the market segment and sub-segments exhibiting promising growth in the forecast timeline. The report also provides deeper insights into the technological advancements, industrial landscape, and emerging product and technological developments in the Esoteric Testing market. It offers fruitful insights into the business sphere to help businesses capitalize on the lucrative growth opportunities.
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Esoteric Testing market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
The leading market contenders listed in the report are:
Laboratory Corporation of America, OPKO Health, Inc., H.U. Group Holdings, Inc., Nordic Lifesciences, Genomic Health, Inc.; American Medical Lab, Invitae Corporation, SYNLAB International GmbH, UNILABS, and Fulgent Genetics
Emergen Research has segmented the global Esoteric Testing market on the basis of type, application, end-use, and region:
Segments Covered in this report are:
Type Outlook (Revenue, USD Billion; 2019-2030)
Infectious Diseases Testing
Oncology testing
Immunology Testing
Others
Techniques Outlook (Revenue, USD Billion; 2019-2030)
ELISA
Flow Cytometry
RT - PCR
Others
Regional Outlook (Revenue, USD Billion; 2019-2030)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
U.A.E.
South Africa
Turkey
Rest of MEA
The various regions analyzed in the report include:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Objectives of the Report:
Analysis and estimation of the Esoteric Testing Market size and share for the projected period of 2022-2030
Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Esoteric Testing Market
Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities
